Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

NCT01212900 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

230

Enrollment

NIH

Sponsor class

Conditions

Atherosclerosis
Hypercholesterolemia

Interventions

DRUG: Statins, HMG CoA

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)